Monte Rosa Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 11/14/2025 | 7.69 M | $57.00 M | 0.00% | 9.36% |
| BVF INC/IL | 11/14/2025 | 5.66 M | $41.94 M | 0.00% | 6.89% |
| VERSANT VENTURE MANAGEMENT, LLC | 11/10/2025 | 5.65 M | $41.89 M | 0.00% | 6.88% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 4.92 M | $36.43 M | 0.00% | 5.98% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 4.64 M | $34.36 M | -26.69% | 5.64% |
| BLACKROCK, INC. | 11/12/2025 | 3.82 M | $28.27 M | -0.81% | 4.64% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 3.36 M | $24.90 M | 0.00% | 4.09% |
| VANGUARD GROUP INC | 11/07/2025 | 2.99 M | $22.15 M | -4.83% | 3.64% |
| FMR LLC | 11/13/2025 | 2.81 M | $20.84 M | 22.91% | 3.42% |
| AISLING CAPITAL MANAGEMENT LP | 11/12/2025 | 1.47 M | $10.91 M | 0.00% | 1.79% |
| ALPHABET INC. | 11/07/2025 | 1.46 M | $10.85 M | 0.00% | 1.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.15 M | $8.53 M | 2.44% | 1.40% |
| MARSHALL WACE, LLP | 11/13/2025 | 902.83 K | $6.69 M | 102.39% | 1.10% |
| STATE STREET CORP | 11/14/2025 | 846.77 K | $6.27 M | 1.80% | 1.03% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 800.00 K | $5.93 M | 100.00% | 0.97% |
| NORTHERN TRUST CORP | 11/14/2025 | 740.68 K | $5.49 M | -2.72% | 0.90% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 717.26 K | $5.31 M | -44.14% | 0.87% |
| PARKWOOD LLC | 11/14/2025 | 708.00 K | $5.25 M | 0.00% | 0.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 694.94 K | $5.15 M | 100.00% | 0.85% |
| MORGAN STANLEY | 11/14/2025 | 645.20 K | $4.78 M | 13.10% | 0.79% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 632.18 K | $4.68 M | 41.06% | 0.77% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 593.39 K | $4.40 M | 47.23% | 0.72% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 444.94 K | $3.30 M | 588.43% | 0.54% |
| ROYAL BANK OF CANADA | 11/14/2025 | 435.77 K | $3.23 M | -7.24% | 0.53% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 408.54 K | $3.03 M | 100.00% | 0.50% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 395.73 K | $2.93 M | -35.66% | 0.48% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 383.27 K | $2.84 M | 0.51% | 0.47% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 358.85 K | $2.66 M | 32.22% | 0.44% |
| JANE STREET GROUP, LLC | 11/14/2025 | 307.05 K | $2.28 M | 100.00% | 0.37% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 269.64 K | $2.00 M | -0.56% | 0.33% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 215.75 K | $1.60 M | 100.00% | 0.26% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 203.55 K | $1.51 M | 341.14% | 0.25% |
| MACQUARIE GROUP LTD | 11/13/2025 | 200.00 K | $1.48 M | 100.00% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 186.80 K | $1.38 M | 6.53% | 0.23% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 172.08 K | $1.28 M | 0.00% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 172.00 K | $1.27 M | 100.00% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 161.48 K | $1.20 M | -32.70% | 0.20% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 158.52 K | $1.17 M | -29.49% | 0.19% |
| JBF CAPITAL, INC. | 11/14/2025 | 148.57 K | $1.10 M | 100.00% | 0.18% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 147.73 K | $1.09 M | -27.38% | 0.18% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 133.46 K | $989.00 K | -52.98% | 0.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 120.90 K | $895.87 K | 924.58% | 0.15% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 118.38 K | $877.22 K | -1.21% | 0.14% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 113.00 K | $837.33 K | 100.00% | 0.14% |
| NUVEEN, LLC | 11/12/2025 | 102.97 K | $762.99 K | 0.00% | 0.13% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 101.14 K | $749.48 K | -70.95% | 0.12% |
| INVESCO LTD. | 11/13/2025 | 97.90 K | $725.43 K | 49.72% | 0.12% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 94.71 K | $701.78 K | -46.83% | 0.12% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 90.42 K | $670.01 K | 100.00% | 0.11% |
| EMPOWERED FUNDS, LLC | 11/13/2025 | 87.45 K | $648.01 K | 100.00% | 0.11% |
Monte Rosa Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 146 institutional investors and hedge funds held shares of Monte Rosa Therapeutics, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 7.69 M
BVF INC/IL: 5.66 M
Versant Venture Management, LLC: 5.65 M
BAKER BROS. ADVISORS LP: 4.92 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.64 M
BlackRock, Inc.: 3.82 M
73.04% of Monte Rosa Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 62.52 M shares in the last 24 months. This purchase volume represents approximately $1.10 B in transactions.